Skip to main content
With this week’s ceremony, Rockefeller has granted Ph.D.s in bioscience to 1,431 students. In addition, Ingrid Daubechies, Marc W. Kirschner, and Evelyn G. Lipper received honorary doctor of science degrees.

Agata Smogorzewska investigates the handful of DNA repair mechanisms that attempt to correct problems, errors, and breakdowns.

The labs of Ali Brivanlou and Charles M. Rice collaborated to refine a cell culture technology platform that grows genetically identical lung buds from human embryonic stem cells.

Despite decades of scientific struggle, progress been excruciatingly slow. But the tide is turning.

Thanks to cryo-em, the breakthroughs are coming faster than ever for Jue Chen. She explains the exciting applications for medicine and science.

The human reference genome has always been a remarkable but flawed tool. A new "pangenome" aims to correct its oversights and omissions.

Research shed light on the process by which the γ-Tubulin Ring Complex stabilizes microtubules, which may inform the study of developmental diseases and cancers.

A new paper describes how choline is transported into the cell, with potentially sweeping implications for the study of rare diseases.

Why do some with COVID end up on ventilators while others get a scratchy throat—and yet others seem to have dodged the virus entirely? Answers are emerging from scientists around the globe.

The study is the first to identify a damage response pathway that is distinct from but parallel to the classical pathway triggered by pathogens.

Damaged gums may release bacteria into the bloodstream that trigger arthritis flare-ups, potentially explaining why people with gum disease don't respond as well to arthritis treatments.

Universal vaccines can give years of protection against polio, measles, and smallpox, among other diseases. Pamela Bjorkman believes HIV, influenza, and COVID are next.

Just as the Rice lab’s work on HCV exposed that virus’s weaknesses, the hope is that this novel approach could do the same for HBV.

Li Zhao studies the intriguing genes that emerge from previously silent or non-coding stretches of DNA.

The anterior thalamus plays such a key role in memory that boosting it in mice consolidates the animals' trivial experiences into long-term memories.

Scientists have built a novel AI system that rewrites the rules for computer vision. It might soon turn neuroscience on its head.

The tech, dubbed MesoLF, captures 10,500 neurons buried at once-inaccessible depths, firing from brain regions many millimeters apart, simultaneously—all with unprecedented resolution.

The author of Finding the Mother Tree: Discovering the Wisdom of the Forest will be presented with Rockefeller’s prestigious science writing award on April 17.

The relatively simple and low-cost procedure could empower laboratories in low-resource areas to generate nanobodies against SARS-CoV-2, as well as other viruses.

The findings offer a new way to understand how some ants become total layabouts.

A molecular chemist whose work has protected millions of people from bacterial meningitis, Gotschlich passed away on February 14. He was 88.

A trio of faulty genes fail to put the brakes on the immune system’s all-out assault on SARS-CoV-2, leading to the inflammatory overload characteristic of MIS-C.

Starving cancer cells of a key amino acid could potentially render tumors more vulnerable to the body’s natural immune response.

Fuchs receives the honor for illuminating the genetics of skin diseases and the mechanisms that guide skin renewal, yielding insights into aging, inflammation, and cancer.

The body's first blush with a pathogen shapes how it will respond to vaccines. New evidence clarifies how this phenomenon works, mechanistically.

A diverse immune response hinges on naive B cells mingling with high affinity ones in the late-stage germinal center. Whether that helps or hinders, however, depends on the virus.

Charles David Allis, a molecular biologist who shaped the field of chromatin biology, died on January 8 at the age of 71.

It's not just the number of mutations that matters. It's the failure to fix them too.

A novel method reduces the time required to identify novel antibiotic-producing DNA from weeks to days.

While most germinal centers shut down after a few weeks, some stay in business for more than six months. A new study helps explain why.